Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology
Brain · 01.02.2024 · 147 (2) · 590-606
DOI: 10.1093/brain/awad309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 13.09.2023. Verfasst von Iain J Hartnell und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Pick Disease of the Brain, Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Research UK, Programs d'Investissements d'Avenir LabEx, Alzheimer’s Research UK.
Abstract (Originalsprache)
Frontotemporal lobar degeneration with tau (FTLD-tau) is a group of tauopathies that underlie ∼50% of FTLD cases. Identification of genetic risk variants related to innate/adaptive immunity have highlighted a role for neuroinflammation and neuroimmune interactions in FTLD. Studies have shown microglial and astrocyte activation together with T cell infiltration in the brain of THY-Tau22 tauopathy mice. However, this remains to be confirmed in FTLD-tau patients. We conducted a detailed post-mortem study of FTLD-tau cases including 45 progressive supranuclear palsy with clinical frontotemporal dementia, 33 Pick’s disease, 12 FTLD-MAPT and 52 control brains to characterize the link between phosphorylated tau (pTau) epitopes and the innate and adaptive immunity. Tau pathology was assessed in the cerebral cortex using antibodies directed against: Tau-2 (phosphorylated and unphosphorylated tau), AT8 (pSer202/pThr205), AT100 (pThr212/pSer214), CP13 (pSer202), PHF1 (pSer396/pSer404), pThr181 and pSer356. The immunophenotypes of microglia and astrocytes were assessed with phenotypic markers (Iba1, CD68, HLA-DR, CD64, CD32a, CD16 for microglia and GFAP, EAAT2, glutamine synthetase and ALDH1L1 for astrocytes). The adaptive immune response was explored via CD4+ and CD8+ T cell quantification and the neuroinflammatory environment was investigated via the expression of 30 inflammatory-related proteins using V-Plex Meso Scale Discovery. As expected, all pTau markers were increased in FTLD-tau cases compared to controls. pSer356 expression was greatest in FTLD-MAPT cases versus controls (P < 0.0001), whereas the expression of other markers was highest in Pick’s disease. Progressive supranuclear palsy with frontotemporal dementia consistently had a lower pTau protein load compared to Pick’s disease across tau epitopes. The only microglial marker increased in FTLD-tau was CD16 (P = 0.0292) and specifically in FTLD-MAPT cases (P = 0.0150). However, several associations were detected between pTau epitopes and microglia, supporting an interplay between them. GFAP expression was increased in FTLD-tau (P = 0.0345) with the highest expression in Pick’s disease (P = 0.0019), while ALDH1L1 was unchanged. Markers of astrocyte glutamate cycling function were reduced in FTLD-tau (P = 0.0075; Pick’s disease: P < 0.0400) implying astrocyte reactivity associated with a decreased glutamate cycling activity, which was further associated with pTau expression. Of the inflammatory proteins assessed in the brain, five chemokines were upregulated in Pick’s disease cases (P < 0.0400), consistent with the recruitment of CD4+ (P = 0.0109) and CD8+ (P = 0.0014) T cells. Of note, the CD8+ T cell infiltration was associated with pTau epitopes and microglial and astrocytic markers. Our results highlight that FTLD-tau is associated with astrocyte reactivity, remarkably little activation of microglia, but involvement of adaptive immunity in the form of chemokine-driven recruitment of T lymphocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.
- Clinical and Experimental Sciences, Faculty of Medicine, Sir Henry Wellcome Laboratories, University of Southampton, Southampton O16 6YD, UK.
- Histochemistry Research Unit, Clinical and Experimental Sciences, Faculty of Medicine University of Southampton, Southampton SO16 6YD, UK.
- Biomedical Imaging Unit, University Hospital Southampton NHS Trust, Southampton SO16 6YD, UK.
- University of Lille, Inserm, CHU Lille, UMR-S1172-Lille Neurosciences and Cognition, Lille 59045, France.
- Alzheimer and Tauopathies, LabEX DISTALZ, Lille 59000, France.
ORCID-Profile: Luc Buee, Guillaume Dorothee, Delphine Boche
Förderung
- Alzheimer's Research UK
- Programs d'Investissements d'Avenir LabEx
- Alzheimer’s Research UK
- Programs d’Investissements d’Avenir LabEx
Zitieren
APA
Hartnell, I. J., Woodhouse, D., Jasper, W., Mason, L., Marwaha, P., Graffeuil, M., Lau, L. C., Norman, J. L., Chatelet, D. S., Buee, L., Nicoll, J. A. R., Blum, D., Dorothee, G., & Boche, D. (2024). Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain, 147(2), 590-606. https://doi.org/10.1093/brain/awad309
Vancouver
Hartnell IJ, Woodhouse D, Jasper W, Mason L, Marwaha P, Graffeuil M, et al. Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology. Brain. 2024;147(2):590-606. doi:10.1093/brain/awad309
BibTeX
@article{Hartnell2024,
author = {Hartnell, Iain J and Woodhouse, Declan and Jasper, William and Mason, Luke and Marwaha, Pavan and Graffeuil, Manon and Lau, Laurie C and Norman, Jeanette L and Chatelet, David S and Buee, Luc and Nicoll, James A R and Blum, David and Dorothee, Guillaume and Boche, Delphine},
title = {Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology},
journal = {Brain},
year = {2024},
volume = {147},
number = {2},
pages = {590--606},
doi = {10.1093/brain/awad309}
}
EUVIMED